Looking for a stock that might be in a good position to beat earnings at its next report? Consider GW Pharmaceuticals plc , a firm in the Medical Products industry, which could be a great candidate for another beat.
This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. In fact, in these reports, GWPH has beaten estimates by at least 35% in both cases, suggesting it has a nice short-term history of crushing expectations.
Earnings in Focus
Two quarters ago, GWPH expected to post a loss of $1.17 per share, while it actually produced a loss of $1.10 per share, a beat of 35.7%. Meanwhile, for the most recent quarter, the company looked to deliver a loss of $1.73 per share, when it actually reported loss of 73 cents per share instead, representing a 57.8% positive surprise.
Thanks in part to this history, recent estimates have been moving higher for GW Pharmaceuticals. In fact, the Earnings ESP for GWPH is positive, which is a great sign of a coming beat.
After all, the Zacks Earnings ESP compares the most accurate estimate to the broad consensus, looking to find stocks that have seen big revisions as of late, suggesting that analysts have recently become more bullish on the company’s earnings prospects. This is the case for GWPH, as the firm currently has a Zacks Earnings ESP of 5.30%, so another beat could be around the corner.
This is particularly true when you consider that GWPH has a great Zacks Rank #1 (Strong Buy) which can be a harbinger of outperformance and a signal for a strong earnings profile. And when you add this solid Zacks Rank to a positive Earnings ESP, a positive earnings surprise happens nearly 70% of the time, so it seems pretty likely that GWPH could see another beat at its next report, especially if recent trends are any guide.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Image: Bigstock
Will GW Pharmaceuticals (GWPH) Crush Estimates at Its Next Earnings Report?
Looking for a stock that might be in a good position to beat earnings at its next report? Consider GW Pharmaceuticals plc , a firm in the Medical Products industry, which could be a great candidate for another beat.
This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. In fact, in these reports, GWPH has beaten estimates by at least 35% in both cases, suggesting it has a nice short-term history of crushing expectations.
Earnings in Focus
Two quarters ago, GWPH expected to post a loss of $1.17 per share, while it actually produced a loss of $1.10 per share, a beat of 35.7%. Meanwhile, for the most recent quarter, the company looked to deliver a loss of $1.73 per share, when it actually reported loss of 73 cents per share instead, representing a 57.8% positive surprise.
GW PHARMA-ADR Price and EPS Surprise
GW PHARMA-ADR Price and EPS Surprise | GW PHARMA-ADR Quote
Thanks in part to this history, recent estimates have been moving higher for GW Pharmaceuticals. In fact, the Earnings ESP for GWPH is positive, which is a great sign of a coming beat.
After all, the Zacks Earnings ESP compares the most accurate estimate to the broad consensus, looking to find stocks that have seen big revisions as of late, suggesting that analysts have recently become more bullish on the company’s earnings prospects. This is the case for GWPH, as the firm currently has a Zacks Earnings ESP of 5.30%, so another beat could be around the corner.
This is particularly true when you consider that GWPH has a great Zacks Rank #1 (Strong Buy) which can be a harbinger of outperformance and a signal for a strong earnings profile. And when you add this solid Zacks Rank to a positive Earnings ESP, a positive earnings surprise happens nearly 70% of the time, so it seems pretty likely that GWPH could see another beat at its next report, especially if recent trends are any guide.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>